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Abstract
Background: World Health Organization (WHO) declared that the outbreak of COVID-19 constituted a public health emergency of
global concern.
Objectives: Owing to limited data on critically ill patients admitted to ICU, we aimed to describe the clinical characteristics and
prognosis of these patients based on ventilatory variables and clinical features.
Methods: In this retrospective study, 45 critically ill patients with laboratory-confirmed COVID-19 who were admitted to Intensive
Care Unit (ICU) wards of the hospital from April 8 to May 9, 2020, were enrolled. Medical files of the patients were reviewed, and
demographic and clinical characteristics, laboratory data, lung CT scan findings, causes of intubation, and outcomes of the patients
were all collected.
Results: The median age of the patients was 67 years (range 22 to 91), 64% were men, and hypertension was the most common
comorbidity. History of close contact with previously confirmed patients was positive in 62.2% of the patients. The mean time from
symptom onset to hospital admission was 5.98 ± 2.93 days. The most common symptoms at the onset of illness were dyspnea
(95.6%), and gastrointestinal symptoms (22.2%) were rare. The average length of the intubation was 4.84± 3.28 days. The distribution
of intubation causes in the deceased patients was significantly more than the recovered patients (P = 0.031). The mean score of lung
CT involvement in deaths (370.26 ± 207.50) was significantly higher than the recovered patients (235.71 ± 81.21) (P = 0.042). Length
of the intubation had a statistically direct correlation with respiratory rate (P = 0.03).
Conclusions: Most of the critically ill patients admitted to ICU were older men and had poor outcomes with a high mortality rate.
Furthermore, the score of chest CT involvement and respiratory rate are important prognostic factors in determining the severity
of the illness, requiring ventilatory support, and outcome.
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1. Background
Severe acute respiratory syndrome coronavirus-2
(SARS-CoV2) is a new strain of coronavirus, which was
first detected in Wuhan, China, in December 2019 (1, 2).
Thus far, coronavirus disease 2019 (COVID-19), caused by
SARS-CoV2, has rapidly infected millions of people around
the world and has become an emerging health threat (3).
On February 19, 2020, Iran reported its first cases diag-
nosed with COVID-19 in Qom; subsequently, the increasing
number of cases recorded in Qom, and finally, throughout
all 31 provinces of the country (4).
COVID-19 is a novel disease with wide clinical manifes-
tations, encompassing asymptomatic or mild upper respi-
ratory tract illness to severe viral pneumonia with acute
respiratory distress syndrome (ARDS) and even death (5).
Whereas most infected people develop mild to moder-
ate illness and recover without hospitalization, about 14%
present with severe symptoms that require hospital care,
and one-third of hospitalized patients need invasive me-
chanical ventilation (6). Critically ill patients with COVID-
19 may develop ARDS, septic shock, sepsis, cardiac injury,
acute kidney injury, and multi-organ dysfunction (7). Al-
though risk factors for severe illness remain unclear, co-
morbidity and older age have been reported as likely im-
portant factors for poor prognosis and death (8, 9).
To date, no specific medication or immunomodulatory
therapy has yet been approved for the treatment of COVID-
19, so the management of critically ill patients is similar to
the management of most viral pneumonia, and supportive
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therapy to control symptoms and to protect multi-organ
function is the priority of the management (10). Therefore,
due to the increase in the number of hospitalized patients
and limited ICU capacity, identifying clinical characteris-
tics and hospital course of severe and ventilated patients
with COVID-19 is crucial to guide decision making regard-
ing ICU capacities and allocation of resources to decrease
the mortality rate. Most of the previous studies have just
reported the general epidemiological, and clinical char-
acteristics of hospital admitted patients with COVID-19,
and there are limited data about the clinical course of se-
vere cases of COVID-19 (7, 9, 11-14). Recently, a case series
from Italy have reported detailed information on venti-
latory parameters, clinical and laboratory characteristics
and have determined prognosis and risk factors of venti-
lated patients with COVID-19 admitted to ICU. Their results
showed that older age and pre-admission hypertension are
the main mortality risk factors (15).
2. Objectives
Accordingly, we aimed to describe the clinical charac-
teristics and prognosis of critically ill patients with COVID-
19 based on ventilatory variables and clinical features.
3. Methods
3.1. Study Population
This retrospective study was done at a teaching hospi-
tal, Tehran, Iran, which is one of the referral centers for the
COVID-19. The inclusion criteria were all consecutive criti-
cally ill patients with laboratory-confirmed COVID-19 who
were admitted to intensive care unit (ICU) wards or trans-
ferred from wards to ICU of the hospital from April 8 to May
9, 2020. The patients without any imaging documents, ei-
ther chest X-ray (CXR) or chest CT were excluded. Drug his-
tory of all enrolled cases was recorded in detail, but this
information was not analyzed. All of the deaths caused by
COVID-19 directly or indirectly and also caused by COVID-
19 complication were recorded as COVID-19 death. Con-
firmed infection was defined as positive real-time poly-
merase chain reaction (RT-PCR) to SARS-CoV-2 in their na-
sopharyngeal specimens (10). Critically ill patients were
defined as intubated patients admitted to ICU who re-
quired mechanical ventilation. The respiratory rate of the
patients was recorded immediately before intubation, and
in case of being higher than the determined limit defined
as tachypnea and the relationship between tachypnea with
intubation time was then analyzed. The Ethics Commis-
sion of Iran University of Medical Sciences approved this
study, and written informed consent was waived due to the
nature of retrospective chart review.
3.2. Data Collection
Medical files of the patients were reviewed for data
collection. We obtained data on demographic, signs and
symptoms upon hospital admission, comorbidities, smok-
ing history, contact exposure, history of influenza vacci-
nation, laboratory data, lung CT scan findings, time from
symptoms to hospital admission, time from hospital ad-
mission to intubation, length of the intubation, causes of
intubation, and outcome data. All data were collected by
two trained investigators.
Causes of intubation were classified into hypoxia and
hypercapnia, hypoxia and tachypnea and hypercapnia, hy-
poxia and tachypnea, hypoxia, hemodynamic instability,
and cardiopulmonary arrest. Hypoxia was defined as SPO2
under 90% or PaO2 under 60 mmHg, hypercapnia was de-
fined as PaCO2 above 50 mmHg, and tachypnea was de-
fined as respiratory rate above 30/min.
Lung CT findings were graded on a scale of 1 - 6 based
on a classification system which had been previously eval-
uated in the other diseases: 1 normal; 2 ground-glass; 3
consolidation; 4 ground-glass with traction bronchiolecta-
sis or bronchiectasis; 5 consolidation with traction bron-
chiolectasis or bronchiectasis, and 6 honeycombing (16,
17). The presence of each of these abnormalities was as-
sessed in three (upper, middle, and lower) zones of each
lung. The percentage of involvement in each zone was es-
timated based on visual criteria by two expert radiologists.
The abnormality score for each zone was calculated by mul-
tiplying the percentage area by the point value (1-6). The
six-zone scores were averaged to determine the total score
for each abnormality in each patient. The overall CT score
for each patient was obtained by adding the six averaged
scores.
3.3. Statistical Analysis
All statistical analyses were performed with the Sta-
tistical Package for Social Sciences version 20.0 (SPSS Inc.,
Chicago, IL, USA). Means ± standard deviation (SD) and
median (with an interquartile range = IQR = Q1-Q3) were
used for continuous variables, and frequencies and pro-
portions were used for categorical variables. Variables of
both groups (death or survival) were compared using χ2
tests or Fisher’s Exact test for proportions and unpaired t-
tests for means. Pearson correlation coefficient was used to
evaluate the association between characteristics with ven-
tilatory variables. A P-value of less than 0.05 was consid-
ered statistically significant.
4. Results
Fifty-four critically ill patients with confirmed COVID-
19 were admitted to the ICU of the teaching hospital and
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Table 1. Baseline Characteristics of Critically Ill Patients with COVID-19
Characteristics Total Number of Patients (%)



















Received annual influenza vaccine
No 39 (86.7)
Yes 6 (13.3)







received mechanical ventilation. Overall, 38 (84.4%) cases
died, and 7 (15.6%) patients were discharged home. The
median age of the patients was 67 years (range 22 to 91),
and 29 of the 45 patients (64%) were male. Most of the pa-
tients had comorbidity (35 [77.7%]), including hypertension
(23 [51.1%]), diabetes (19 [42.2%]), cardiovascular disease (6
[13.3%]), and asthma (3 [6.7%]). In addition, 8 (17.8%) patients
have a history of smoking, 6(13.3%) patients had a history of
receiving annual influenza vaccine, and 28 (62.2%) patients
had a history of close contact with previously confirmed
patients. Table 1 represents the baseline characteristics of
the patients.
The mean time from symptoms to hospital admission
Table 2. Signs and Symptoms Upon Hospital Admission of Critically Ill Patients with
COVID-19
Signs and Symptoms Upon Hospital
Admission

























was 5.98± 2.93 days, and from illness onset to dyspnea was
2.73 ± 3.07 days. Dyspnea (95.6%), SPO2 depression (93.3%),
and fever (80%) were the most common signs and symp-
toms upon hospital admission. Gastrointestinal symp-
toms were rare (diarrhea [13.3%], and nausea and vomiting
[8.9%]) (Table 2). The average hospital admission to intu-
bation time was 2.33 ± 2.65 days. The average length of
the intubation was 4.84 ± 3.28 days. The causes of intuba-
tion were hypoxia and tachypnea 13 (28.88%), hypoxia and
hypercapnia 10 (22.22%), hypoxia 8 (17.77%), hypoxia and
tachypnea and hypercapnia 7 (15.55%), hemodynamic insta-
bility 4 (8.88%), and cardiopulmonary arrest 3 (6.66%). Dis-
tribution of intubation causes in the deceased patients was
significantly higher in the recovered patients (P = 0.031)
(Table 3).
The mean score of lung CT findings in the deceased pa-
tients (370.26 ± 207.50) was significantly higher than the
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Patients (N = 7)
Deaths (N = 38)
Hypoxia and
hypercapnia




7 (15.6) 0 (0.0) 7 (18.4)
Hypoxia and
tachypnea
13 (28.9) 1 (14.3) 12 (31.5)
Hypoxia 8 (17.8) 1 (14.3) 7 (18.4)
Hemodynamic
instability
4 (8.9) 0 (0.0) 4 (10.5)
Cardiopulmonary
arrest
3 (6.7) 0 (0.0) 3 (7.9)
recovered patients (235.71± 81.21) (P = 0.042). Additionally,
we analyzed the association of clinical and laboratory vari-
ables with causes of intubation (Table 4). Results show no
statistically correlation between LDH, length of the intuba-
tion, SPO2, pH, and cause of intubation (P > 0.05), while res-
piratory rate, PaO2, PaCO2, and CT scores had a statistically
direct correlation (P < 0.05). The correlation between av-
erage hospital admission to intubation time and average
length of the intubation was studied with variables LDH,
SPO2, pH, respiratory rate, PaO2, PaCO2 that results showed
a statistically direct correlation between average hospital
admission to intubation time and PaCO2 (P = 0.023) and a
statistically direct correlation between the average length
of the intubation and respiratory rate (P = 0.03). The cor-
relation between other variables was not significant (P >
0.05) (Table 5).
5. Discussion
This retrospective study describes the clinical course
and outcomes of 54 critically ill patients with laboratory-
confirmed COVID-19 infection who intubated and admit-
ted in ICU wards. As mentioned in previous studies, the
population in this study mostly consisted of men (64%) and
was generally older (median age, 67 years; range, 22 - 91
years) than previous case series admitted to ICU in China,
Italy, and America (11-15). Although previous evidence sug-
gests that older and male patients are the most suscepti-
ble individuals to COVID-19, we cannot consider older age
and male gender as a risk factor for admission to the ICU or
poor prognosis.
In our case series, dyspnea followed by SPO2 depres-
sion, fever, and cough were the most prevalent symptoms
on admission among critically ill patients with COVID-19,
which is in accordance with previous studies (18). It seems
that clinical presentations of COVID-19 are relatively simi-
lar to other betacoronavirus infections. Furthermore, less
than 15% of the patients had gastrointestinal symptoms,
and this was consistent with the results from other pre-
vious studies. However, the incidence of gastrointestinal
symptoms in patients with MERS-CoV or SARS-CoV infec-
tion has been reported about 20% - 25% (19, 20).
In accordance with the recent reports, our study re-
ported that 77.7% of the critically ill patients had at least
one comorbidity. This is similar to what was reported by
Wang et al. (72.2%), and it was 86% in another case series
in the USA (13, 21). Hypertension was the most common co-
morbidity in our study, this is similar to what was reported
by other previous studies (18). Moreover, the majority of
the patients (62.2%) had a history of close contact with in-
fected patients. This was concordant with the results from
Bhatraju et al. (13) reported 54% had recent contact with an
infected patient.
Previous studies reported a wide range of mortality
rates among critically ill patients admitted to ICU, from 16%
to 38%, 62%, 67%, and 80% (12-15, 22-24). In our study, over-
all outcomes were poor in severe patients who received
ICU care, and the mortality rate (84.6%) was considerably
higher than other studies. In fact, we reported the final out-
comes of the patients, but previous studies just followed
the patients for a limited time. Therefore, the majority of
the patients were still in the ICU or hospital at the time of
gathering data, and there is an underestimation in report-
ing mortality rate by previous studies. For example, a large
Italian case series reported 26% mortality rate at 5 weeks af-
ter ICU admission; however, more than 50% of the patients
were still in the ICU at the time of submission, and their
outcome remains uncertain (14). In addition, we just re-
ported data from intubated patients and those requiring
mechanical ventilation. In a case series from Wuhan, the
mortality rate among critically ill patients was 62%, and it
was 81% among those requiring mechanical ventilation (8).
In agreement with the previous reports, our study con-
firmed that all patients had abnormal findings in chest CT
scan, and bilateral multiple lobular and subsegmental ar-
eas of consolidation were the most frequent chest CT find-
ings among ICU patients (8). Additionally, we observed
that non-survivors had a significantly higher score of lung
CT involvement than survivors. This finding supports the
score of chest CT involvement as a prognostic factor in out-
comes of severe patients with COVID-19.
Our findings revealed that the majority of patients in
this case series intubated and required mechanical ven-
tilation because of hypoxemic, hypercapnic, and tachyp-
neic respiratory failure. This finding supports the results
of previous studies that reported respiratory failure and
developed ARDS were the main reasons for intubation and
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Pearson correlation 1 0.030 -0.108 0.109 -0.174 0.167 0.169 0.338a
Sig. (2-tailed) 0.847 0.480 0.475 0.253 0.273 0.267 0.023
Number 45 45 45 45 45 45 45 45
Duration of mechanical
ventilation, d
Pearson correlation 0.030 1 -0.146 0.085 0.075 -0.325a -0.220 0.070
Sig. (2-tailed) 0.847 0.338 0.580 0.625 0.030 0.147 0.645
Number 45 45 45 45 45 45 45 45
aCorrelation is significant at 0.05 level (2-tailed).
ICU admission among critically ill patients with COVID-19
(15, 18). Furthermore, respiratory rate, PaO2, PaCO2, and CT
score had a statistically direct correlation with the distri-
bution causes of intubation.
As new findings, our study demonstrated that the
length of the intubation had a direct correlation with res-
piratory rate. In fact, the length of intubation would be
longer in critically ill patients who had higher respiratory
rates on admission. Therefore, we can consider the respi-
ratory rate as a prognostic factor for the length of the in-
tubation. This is not investigated in other studies. We can
argue that the patients with higher respiratory rate have
more lung involvement and greater decline in pulmonary
function, so they will require mechanical ventilation and
oxygen support longer than other patients.
Our study has some strong points that must be high-
lighted. First, the data represents certain outcomes of
the patients, and the patients were fully recovered or de-
ceased at the time of data collection. Second, we investi-
gated the causes of intubation and scoring lung CT involve-
ment among intubated patients as new aspects of the clin-
ical features of critically ill patients with COVID-19. On the
other hand, the small sample size and single-center study
were the main limitations of the current study. Finally, we
suggest that this study could be performed on a larger sam-
ple size and multicenter to clarify risk factors and prog-
nostic factors, especially among intubated patients with
COVID-19.
In summary, it was concluded that most of the crit-
ically ill patients admitted to ICU were older men and
had poor outcomes with a high mortality rate. Further-
more, the score of chest CT involvement and respiratory
rate are important prognostic factors in determining the
severity of illness, requiring ventilatory support, and out-
come. Considering the causes of intubation, especially res-
piratory distress among critically ill patients, the impor-
tance of earlier cardiac monitoring and ventilatory sup-
port, must be highlighted.
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Table 4. Association Between Clinical and Laboratory Variables with Causes of Intubation
Characteristics Number Mean ± SD P-Value
LDH 0.351
Hypoxia and hypercapnia 10 942.30 ± 160.55
Hypoxia, tachypnea, and hypercapnia 7 951.86 ± 299.61
Hypoxia, and tachypnea 13 1213.9 ± 399.64
Hypoxia 8 1093.75 ± 193.63
Hemodynamic instability 4 1103.75 ± 175.65
Cardiopulmonary arrest 3 939.00 ± 161.65
Total 45 1063.31 ± 289.32
Duration of mechanical ventilation, d 0.073
Hypoxia and hypercapnia 10 7.50 ± 3.56
Hypoxia, tachypnea, and hypercapnia 7 4.57 ± 3.10
Hypoxia and tachypnea 13 3.62 ± 2.21
Hypoxia 8 5.13 ± 3.94
Hemodynamic instability 4 3.75 ± 2.21
Cardiopulmonary arrest 3 2.67 ± 2.08
Total 45 4.84 ± 3.28
SPO2 0.574
Hypoxia and hypercapnia 10 69.10 ± 8.34
Hypoxia, tachypnea, and hypercapnia 7 63.71 ± 10.16
Hypoxia and tachypnea 13 57.08 ± 16.59
Hypoxia 8 67.38 ± 2.32
Hemodynamic instability 4 63.50 ± 14.43
Cardiopulmonary arrest 3 67.00 ± 19.31
Total 45 63.84 ± 12.57
pH 0.175
Hypoxia and hypercapnia 10 7.35 ± 0.0870
Hypoxia, tachypnea, and hypercapnia 7 7.27 ± 0.1575
Hypoxia and tachypnea 13 7.35 ± 0.0906
Hypoxia 8 7.39 ± 0.0261
Hemodynamic instability 4 7.35 ± 0.0544
Cardiopulmonary arrest 3 7.29 ± 0.1997
Total 45 7.34 ± 0.1041
Respiratory rate < 0.001
Hypoxia and hypercapnia 10 23.90 ± 2.28
Hypoxia, tachypnea, and hypercapnia 7 38.43 ± 3.82
Hypoxia and tachypnea 13 34.92 ± 4.64
Hypoxia 8 25.13 ± 0.35
Hemodynamic instability 4 36.00 ± 7.34
Cardiopulmonary arrest 3 27.67 ± 7.37
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Total 45 30.89 ± 7.01
PaO2 0.01
Hypoxia and hypercapnia 10 35.30 ± 10.84
Hypoxia, tachypnea, and hypercapnia 7 46.42 ± 10.65
Hypoxia and tachypnea 13 27.23 ± 11.42
Hypoxia 8 36.50 ± 9.28
Hemodynamic instability 4 33.87 ± 6.63
Cardiopulmonary arrest 3 47.333 ± 11.37
Total 45 35.58 ± 12.12
PaCO2 < 0.001
Hypoxia and hypercapnia 10 55.60 ± 3.71
Hypoxia, tachypnea, and hypercapnia 7 73.43 ± 19.57
Hypoxia and tachypnea 13 38.23 ± 8.41
Hypoxia 8 34.75 ± 4.83
Hemodynamic instability 4 38.75 ± 5.79
Cardiopulmonary arrest 3 81.33 ± 59.53
Total 45 49.87 ± 22.30
Lung CT findings score 0.014
Hypoxia and hypercapnia 10 232.00 ± 30.111
Hypoxia, tachypnea, and hypercapnia 7 304.29 ± 147.858
Hypoxia and tachypnea 13 463.08 ± 256.950
Hypoxia 8 337.50 ± 231.686
Hemodynamic instability 4 457.50 ± 96.047
Cardiopulmonary arrest 3 240.00 ± 20.000
Total 45 349.33 ± 198.842
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